Showing results (1351-1360 of 1,893) with videos related to

Sort By:
Pageof 190
Immunotherapy|March 20, 2024
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158Jianming Xu, Yimin Mao, Nong Xu, et al.
Immunotherapy|August 1, 2023
Successful treatment with carboplatin and paclitaxel in melanoma progression after immune-related adverse eventsÖzgecan Dülgar, Aditi Saha, Kelly M Elleson, et al.
Immunotherapy|April 17, 2024
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's diseaseFrancesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, et al.
Immunotherapy|September 4, 2023
Tumor lysis syndrome induced by tebentafuspTheresa Ruf, Anna Leonhardt, David Anz, et al.
Immunotherapy|September 11, 2023
Modification of allergen subcutaneous immunotherapy safety precautions and systemic allergic reaction rate reductionKeren Mahlab-Guri, David Mishayev, Marina Yakovlev, et al.
Immunotherapy|September 11, 2023
Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settingsKe Zu, Ashwini Arunachalam, Andriana Hohlbauch, et al.
Immunotherapy|March 15, 2011
Antibody-targeted nanoparticles for cancer therapyFrancois Fay, Christopher J Scott
Immunotherapy|July 13, 2026
The long-term effectiveness of specific immunotherapy in cat allergy: a real-life studyNilay Orak Akbay, Dilşad Mungan, Betül Ayşe Sin
Immunotherapy|July 6, 2026
Utility of serum Krebs von den Lungen-6 and surfactant protein D levels for differential diagnosis of immune checkpoint inhibitor-related pneumonitisShogo Nakai, Masato Karayama, Yusuke Inoue, et al.
Immunotherapy|May 27, 2026
Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosisTablo Ahmed Merza Mohammed, Teshk Nouri Shawis, Talar Ahmad Merza Mohammad, et al.
Pageof 190